Dolby Laboratories, Inc. DLB
Set alert
At close · Oct 30
After hours · Oct 30, 4:01 PM ET
- YTD
- -3.47%
- 1 year
- -5.59%
- Open
- 63.07
- Prev close
- 62.91
- Mkt cap
- 5.81B
- Vol
- 688.77K
- Avg vol
- 866.01K
- EPS
- 2.35
- P/E
- 26.38
- Div yield
- 2.29%
More statistics
- Low
- 61.54
- High
- 63.41
- Forward P/E
- 13.54
- Beta
- 0.78
- Short ratio
- 7.01
- Inst. own
- 107.47%
- Dividend
- 1.44
- Ex-div date
- Aug 10, 2026
- Earnings
- Nov 17, 2026
- 50-d avg
- 60.82
- 200-d avg
- 59.28
- 1y target
- 79.00
5D chart
Signals (111)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 29, 3:50 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:50 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 3:50 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:45 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:45 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 3:45 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 3:30 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:15 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:10 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:00 PM | 2 days ago |
| SMA: Bearish | Oct 29, 2:35 PM | 2 days ago |
| SMA: Bearish | Oct 29, 2:20 PM | 2 days ago |
| SMA: Bullish | Oct 29, 2:15 PM | 2 days ago |
| SMA: Bullish | Oct 29, 2:15 PM | 2 days ago |
| SMA: Bearish | Oct 29, 1:50 PM | 2 days ago |
| SMA: Bearish | Oct 29, 1:45 PM | 2 days ago |
| SMA: Bullish | Oct 29, 1:05 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 12:35 PM | 2 days ago |
| SMA: Bearish | Oct 29, 12:30 PM | 2 days ago |
| RSI: Overbought | Oct 29, 11:55 AM | 2 days ago |
| RSI: Overbought | Oct 29, 11:35 AM | 2 days ago |
| SMA: Bullish | Oct 29, 10:55 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:50 AM | 2 days ago |
| SMA: Bullish | Oct 29, 10:40 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:20 AM | 3 days ago |
| SMA: Bullish | Oct 29, 9:35 AM | 3 days ago |
| SMA: Bullish | Oct 29, 9:35 AM | 3 days ago |
| SMA: Bearish | Oct 29, 9:30 AM | 3 days ago |
| SMA: Bearish | Oct 29, 9:30 AM | 3 days ago |
| SMA: Bullish | Oct 28, 3:55 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 3:30 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:25 PM | 3 days ago |
| RSI: Oversold | Oct 28, 2:55 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 2:20 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:00 PM | 3 days ago |
| SMA: Bearish | Oct 28, 2:00 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:50 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:35 PM | 3 days ago |
| SMA: Bearish | Oct 28, 12:55 PM | 3 days ago |
| SMA: Bullish | Oct 28, 12:50 PM | 3 days ago |
| RSI: Oversold | Oct 28, 12:35 PM | 3 days ago |
| SMA: Bearish | Oct 28, 12:15 PM | 3 days ago |
| SMA: Bullish | Oct 28, 12:10 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 12:05 PM | 3 days ago |
| RSI: Oversold | Oct 28, 11:20 AM | 3 days ago |
| SMA: Bearish | Oct 28, 10:20 AM | 4 days ago |
| SMA: Bullish | Oct 28, 10:00 AM | 4 days ago |
| RSI: Oversold | Oct 28, 9:30 AM | 4 days ago |
| SMA: Bearish | Oct 27, 3:30 PM | 4 days ago |
| SMA: Bullish | Oct 27, 3:25 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 2:25 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:10 PM | 4 days ago |
| SMA: Bearish | Oct 27, 2:05 PM | 4 days ago |
| RSI: Overbought | Oct 27, 1:30 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 1:15 PM | 4 days ago |
| SMA: Bullish | Oct 27, 1:00 PM | 4 days ago |
| SMA: Bullish | Oct 27, 12:55 PM | 4 days ago |
| SMA: Bearish | Oct 27, 12:50 PM | 4 days ago |
| SMA: Bearish | Oct 27, 12:50 PM | 4 days ago |
| SMA: Bullish | Oct 27, 12:40 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 12:15 PM | 4 days ago |
| SMA: Bearish | Oct 27, 12:10 PM | 4 days ago |
| SMA: Bullish | Oct 27, 11:00 AM | 4 days ago |
| MACD: Buy Signal | Oct 27, 10:55 AM | 4 days ago |
| SMA: Bullish | Oct 27, 10:30 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:25 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:15 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:35 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 9:30 AM | 5 days ago |
| RSI: Overbought | Oct 26, 3:15 PM | 5 days ago |
| SMA: Bullish | Oct 26, 3:05 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:55 PM | 5 days ago |
| RSI: Overbought | Oct 26, 2:10 PM | 5 days ago |
| SMA: Bullish | Oct 26, 1:10 PM | 5 days ago |
| SMA: Bullish | Oct 26, 1:00 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 1:00 PM | 5 days ago |
| RSI: Oversold | Oct 26, 12:20 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 11:55 AM | 5 days ago |
| RSI: Oversold | Oct 26, 11:55 AM | 5 days ago |
| SMA: Bearish | Oct 26, 11:45 AM | 5 days ago |
| SMA: Bullish | Oct 26, 11:40 AM | 5 days ago |
| SMA: Bearish | Oct 26, 11:35 AM | 5 days ago |
| SMA: Bullish | Oct 26, 11:25 AM | 5 days ago |
| MACD: Buy Signal | Oct 26, 11:25 AM | 5 days ago |
| RSI: Oversold | Oct 26, 11:20 AM | 5 days ago |
| RSI: Oversold | Oct 26, 10:55 AM | 5 days ago |
| SMA: Bullish | Oct 26, 10:30 AM | 6 days ago |
| RSI: Oversold | Oct 26, 9:45 AM | 6 days ago |
| SMA: Bearish | Oct 23, 3:35 PM | 1 week ago |
| SMA: Bullish | Oct 23, 3:30 PM | 1 week ago |
| SMA: Bullish | Oct 23, 3:15 PM | 1 week ago |
| SMA: Bearish | Oct 23, 3:10 PM | 1 week ago |
| MACD: Sell Signal | Oct 23, 3:00 PM | 1 week ago |
| SMA: Bearish | Oct 23, 2:55 PM | 1 week ago |
| SMA: Bullish | Oct 23, 2:50 PM | 1 week ago |
| SMA: Bearish | Oct 23, 2:45 PM | 1 week ago |
| SMA: Bullish | Oct 23, 1:30 PM | 1 week ago |
| SMA: Bullish | Oct 23, 1:25 PM | 1 week ago |
| SMA: Bearish | Oct 23, 1:20 PM | 1 week ago |
| SMA: Bearish | Oct 23, 1:20 PM | 1 week ago |
| SMA: Bullish | Oct 23, 1:00 PM | 1 week ago |
| SMA: Bearish | Oct 23, 12:50 PM | 1 week ago |
| SMA: Bearish | Oct 23, 12:50 PM | 1 week ago |
| SMA: Bullish | Oct 23, 12:40 PM | 1 week ago |
| SMA: Bullish | Oct 23, 12:35 PM | 1 week ago |
| SMA: Bearish | Oct 23, 12:25 PM | 1 week ago |
| SMA: Bearish | Oct 23, 12:20 PM | 1 week ago |
| SMA: Bullish | Oct 23, 12:15 PM | 1 week ago |
| SMA: Bearish | Oct 23, 11:05 AM | 1 week ago |
| SMA: Bullish | Oct 23, 10:55 AM | 1 week ago |
News
3 days ago globenewswire.com
CervoMed Announces Publication of Two Peer-Reviewed Research Articles Supporting Neflamapimod as a Potential Treatment for Dementia with Lewy Bodies (DLB)
Placebo-controlled results of RewinD-LB clinical trial published in Alzheimer's Research & Therapy provides further evidence of the potential of neflamapimod to slow clinical disease progression in…
2 weeks ago prnewswire.com
Dolby Laboratories Announces Conference Call and Webcast for Q4 Fiscal 2026 Financial Results
SAN FRANCISCO, Oct. 12, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment, will release financial results for the fourth quarter (Q4) and full year fiscal…
2 weeks ago defenseworld.net
Dolby Laboratories (NYSE:DLB) & Palo Alto Networks (NASDAQ:PANW) Financial Contrast
Dolby Laboratories (NYSE: DLB - Get Free Report) and Palo Alto Networks (NASDAQ: PANW - Get Free Report) are both technology companies, but which is the superior investment? We will compare the two…
3 weeks ago defenseworld.net
Analyzing Dolby Laboratories (NYSE:DLB) & Aware (NASDAQ:AWRE)
Dolby Laboratories (NYSE: DLB - Get Free Report) and Aware (NASDAQ: AWRE - Get Free Report) are both technology companies, but which is the superior investment? We will contrast the two businesses…
3 weeks ago seekingalpha.com
Dolby Laboratories: Weak Growth, But The Valuation Is Too Cheap
Dolby Laboratories is rated Buy due to its high margins, robust buyback program, and undervalued share price despite weak growth. DLB's 90% gross margin and operating leverage enable EPS growth even…
1 month ago globenewswire.com
Cognition Therapeutics Schedules a Type C Meeting with FDA to Align on Endpoints for Phase 3 Trial of Zervimesine (CT1812) in DLB
October 20th Meeting with the Division of Neurology Expected to Define Endpoint for Phase 3 October 20th Meeting with the Division of Neurology Expected to Define Endpoint for Phase 3
1 month ago zacks.com
Dolby Expands Meta Partnership With Atmos and Vision Across Devices
DLB expands across Meta's ecosystem as Dolby Atmos and Vision reach AI glasses, Instagram and VR, broadening its digital content footprint.
1 month ago benzinga.com
Your Meta AI Glasses Are Getting a Dolby Upgrade
Meta expands Dolby Atmos & Vision across AI glasses, Instagram, and VR. Get the tech details and DLB stock forecast here.
1 month ago defenseworld.net
Financial Analysis: Zscaler (NASDAQ:ZS) vs. Dolby Laboratories (NYSE:DLB)
Dolby Laboratories (NYSE: DLB - Get Free Report) and Zscaler (NASDAQ: ZS - Get Free Report) are both technology companies, but which is the superior stock? We will compare the two businesses based on…
1 month ago gurufocus.com
Dolby and Meta Expand Dolby Atmos and Dolby Vision Across Meta's Ecosystem
Dolby and Meta Expand Dolby Atmos and Dolby Vision Across Meta's EcosystemPR NewswireSAN FRANCISCO and MENLO PARK, Calif., Sept. 23, 2026 Across Meta AI glasses
1 month ago prnewswire.com
Dolby and Meta Expand Dolby Atmos and Dolby Vision Across Meta's Ecosystem
/PRNewswire/ -- Today, Dolby Laboratories (NYSE: DLB) and Meta (NASDAQ: META) announced the expansion of Dolby experiences within the Meta ecosystem of devices
1 month ago prnewswire.com
Dolby Laboratories, Inc. Grants Inducement Equity Awards Under Its 2026 Inducement Stock Plan
SAN FRANCISCO, Sept. 15, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB) ("Dolby"), a leader in immersive entertainment, today announced it has granted inducement awards under its 2026…
1 month ago prnewswire.com
Dolby Expands Dolby OptiView Platform with New Capabilities at IBC 2026
New Sports Intelligence helps providers better understand and deepen fan engagement, as Dolby Vision comes to the platform alongside updates to Dolby OptiView Ads AMSTERDAM, Sept. 10, 2026…
2 months ago zacks.com
Dolby Laboratories (DLB) is a Top-Ranked Growth Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
2 months ago zacks.com
3 Audio Video Stocks to Watch as the Industry Grapples With Headwinds
Amid cautious discretionary spending and macro troubles, investments in cutting-edge solutions are likely to aid Zacks Audio Video Production industry participants like SONY, DLB and SONO.
2 months ago zacks.com
Dolby Laboratories (DLB) is a Top-Ranked Momentum Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
2 months ago defenseworld.net
Critical Review: Artificial Life (OTCMKTS:ALIF) & Dolby Laboratories (NYSE:DLB)
Artificial Life (OTCMKTS:ALIF - Get Free Report) and Dolby Laboratories (NYSE: DLB - Get Free Report) are both technology companies, but which is the superior stock? We will compare the two companies…
2 months ago prnewswire.com
Dolby Laboratories Announces Leadership Transition
Kevin Yeaman to Retire from Dolby Marc Whitten Named President, Chief Executive Officer and Director of Dolby SAN FRANCISCO, Aug. 27, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), today…
2 months ago gurufocus.com
Cinemo, Dolby, and SmashLabs Bring In-Car Immersive Gaming Experiences to the Next Level
Cinemo, a global leader and one-stop-shop provider for fully integrated, innovative multi-device in-car infotainment solutions, today announced a collaboration
2 months ago seekingalpha.com
Dividend Champion, Contender, And Challenger Highlights: Week August 16
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
2 months ago defenseworld.net
Assenagon Asset Management S.A. Has $5.48 Million Position in Dolby Laboratories $DLB
Assenagon Asset Management S.A. increased its stake in shares of Dolby Laboratories (NYSE: DLB) by 88.9% during the undefined quarter, according to the company in its most recent disclosure with the…
3 months ago benzinga.com
Stock Market Today: Amazon Jumps 15%, Apple Wipes Out $475 Billion
Amazon surges 15% on an AWS blowout while Apple sheds nearly $475 billion in value. Yields sit at cycle highs.
3 months ago benzinga.com
AXT Posts Upbeat Q2 Earnings, Joins Newell Brands, SPX Technologies, Amazon And Other Big Stocks Moving Higher On Friday
U.S. stocks mixed, Nasdaq up 50 pts. AXT Inc (NASDAQ: AXTI) rose 25.3% on strong Q2 results. Other gainers include NWL, FET, IESC, SPXC, AMZN, SPSC, DLB, GH, DXCM, and MPWR.
-
3 months ago benzinga.com
Dolby Laboratories Lowers FY2026 GAAP EPS Guidance from $2.66-$2.81 to $2.62-$2.77 vs $2.83 Est
Dolby Laboratories (NYSE:DLB) lowers FY2026 GAAP EPS guidance from $2.66-$2.81 to $2.62-$2.77 vs $2.83 analyst estimate..
-
3 months ago benzinga.com
Dolby Laboratories Lowers FY2026 Adj EPS Guidance from $4.30-$4.45 to $4.25-$4.40 vs $4.30 Est; Narrows FY2026 Sales Guidance from $1.400B-$1.450B to $1.410B-$1.440B vs $1.407B Est
Dolby Laboratories (NYSE:DLB) lowers FY2026 Adj EPS guidance from $4.30-$4.45 to $4.25-$4.40 vs $4.30 analyst estimate. Narrows FY2026 sales outlook from $1.400 billion-$1.450 billion to $1.410…
-
3 months ago benzinga.com
Dolby Laboratories Sees Q4 Adj EPS $1.13-$1.28 vs $1.20 Est; Sees Sales $362.000M-$392.000M vs $351.950M Est
Dolby Laboratories (NYSE:DLB) is looking for Q4 Adj EPS of $1.13-$1.28 vs $1.20 analyst estimate. sees sales of $362.000 million-$392.000 million vs $351.950 million analyst estimate.
-
3 months ago benzinga.com
Dolby Laboratories Q3 Adj. EPS $0.69 Beats $0.67 Estimate, Sales $304.995M Miss $311.960M Estimate
Dolby Laboratories (NYSE:DLB) reported quarterly earnings of $0.69 per share which beat the analyst consensus estimate of $0.67 by 2.99 percent. This is a 11.54 percent decrease over earnings of…
3 months ago benzinga.com
Top 3 Tech Stocks That May Rocket Higher In July
Find bargains in oversold IT stocks with RSI values below 30: Fabrinet (NYSE: FN), Dolby Laboratories (NYSE: DLB), Oracle Corp (NYSE: ORCL)
6 months ago benzinga.com
Stock Market Today: Apple Earnings Power S&P 500, Nasdaq To Records; Trump Hits EU
U.S. stocks hit fresh records as Apple's blowout Q2 powered Big Tech, while crude oil sank 3% on Hormuz news and Trump set 25% EU auto tariffs.
6 months ago benzinga.com
Dolby Laboratories Q2 2026 Earnings Call: Complete Transcript
Dolby Laboratories Q2 2026 Earnings Call: Complete Transcript
6 months ago benzinga.com
12 Information Technology Stocks Moving In Thursday's After-Market Session
12 Information Technology Stocks Moving In Thursday's After-Market Session
-
6 months ago benzinga.com
Dolby Laboratories Sees Q3 Adj EPS $0.56-$0.71 vs $0.98 Est; Sees Sales $295.000M-$325.000M vs $343.538M Est
Dolby Laboratories (NYSE:DLB) is looking for Q3 Adj EPS of $0.56-$0.71 vs $0.98 analyst estimate. sees sales of $295.000 million-$325.000 million vs $343.538 million analyst estimate.
-
6 months ago benzinga.com
Dolby Laboratories Lowers FY2026 GAAP EPS Guidance from $2.71-$2.86 to $2.66-$2.81 vs $2.77 Est
Dolby Laboratories (NYSE:DLB) lowers FY2026 GAAP EPS guidance from $2.71-$2.86 to $2.66-$2.81 vs $2.77 analyst estimate..
-
6 months ago benzinga.com
Dolby Laboratories Affirms FY2026 Adj EPS Guidance of $4.30-$4.45 vs $4.33 Est; Affirms FY2026 Sales Guidance of $1.400B-$1.450B vs $1.417B Est
Dolby Laboratories (NYSE:DLB) affirms FY2026 Adj EPS guidance from $4.30-$4.45 to $4.30-$4.45 vs $4.33 analyst estimate. Affirms FY2026 sales outlook from $1.400 billion-$1.450 billion to $1.400…
-
6 months ago benzinga.com
Dolby Laboratories Q2 Adj. EPS $1.37 Beats $1.33 Estimate, Sales $395.630M Beat $385.801M Estimate
Dolby Laboratories (NYSE:DLB) reported quarterly earnings of $1.37 per share which beat the analyst consensus estimate of $1.33 by 3.01 percent. This is a 2.24 percent increase over earnings of $1.34…
6 months ago benzinga.com
Earnings Scheduled For April 30, 2026
Earnings Scheduled For April 30, 2026
-
9 months ago benzinga.com
Barrington Research Maintains Outperform on Dolby Laboratories, Maintains $90 Price Target
Barrington Research analyst Patrick Sholl maintains Dolby Laboratories (NYSE:DLB) with a Outperform and maintains $90 price target.
-
9 months ago benzinga.com
Rosenblatt Maintains Buy on Dolby Laboratories, Maintains $85 Price Target
Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and maintains $85 price target.
-
9 months ago benzinga.com
Dolby Laboratories Raises FY2026 GAAP EPS Guidance from $2.61-$2.76 to $2.71-$2.86 vs $2.78 Est
Dolby Laboratories (NYSE:DLB) raises FY2026 GAAP EPS guidance from $2.61-$2.76 to $2.71-$2.86 vs $2.78 analyst estimate..
-
9 months ago benzinga.com
Dolby Laboratories Raises FY2026 Adj EPS Guidance from $4.19-$4.34 to $4.30-$4.45 vs $4.23 Est; Raises FY2026 Sales Guidance from $1.390B-$1.440B to $1.400B-$1.450B vs $1.406B Est
Dolby Laboratories (NYSE:DLB) raises FY2026 Adj EPS guidance from $4.19-$4.34 to $4.30-$4.45 vs $4.23 analyst estimate. Raises FY2026 sales outlook from $1.390 billion-$1.440 billion to $1.400…
-
9 months ago benzinga.com
Dolby Laboratories Sees Q2 Adj EPS $1.29-$1.44 vs $1.37 Est; Sees Sales $375.000M-$405.000M vs $379.185M Est
Dolby Laboratories (NYSE:DLB) is looking for Q2 Adj EPS of $1.29-$1.44 vs $1.37 analyst estimate. sees sales of $375.000 million-$405.000 million vs $379.185 million analyst estimate.
9 months ago benzinga.com
Dolby Laboratories: Q1 Earnings Insights
Dolby Laboratories: Q1 Earnings Insights
-
9 months ago benzinga.com
Dolby Laboratories Q1 Adj. EPS $1.06 Beats $0.88 Estimate, Sales $346.706M Beat $332.073M Estimate
Dolby Laboratories (NYSE:DLB) reported quarterly earnings of $1.06 per share which beat the analyst consensus estimate of $0.88 by 20.87 percent. This is a 7.02 percent decrease over earnings of…
-
9 months ago benzinga.com
Earnings Scheduled For January 29, 2026
Earnings Scheduled For January 29, 2026
9 months ago benzinga.com
An Overview of Dolby Laboratories's Earnings
An Overview of Dolby Laboratories's Earnings
9 months ago benzinga.com
What Analysts Are Saying About Dolby Laboratories Stock
What Analysts Are Saying About Dolby Laboratories Stock
-
9 months ago benzinga.com
Rosenblatt Maintains Buy on Dolby Laboratories, Maintains $85 Price Target
Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and maintains $85 price target.
-
9 months ago benzinga.com
From Flat To Full Immersion: The AWS Path To Dolby Vision And Dolby Atmos
https://aws.amazon.com/blogs/media/from-flat-to-full-immersion-the-aws-path-to-dolby-vision-and-dolby-atmos/
-
11 months ago benzinga.com
Rosenblatt Maintains Buy on Dolby Laboratories, Lowers Price Target to $85
Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and lowers the price target from $95 to $85.
-
11 months ago benzinga.com
Dolby Laboratories Sees FY2026 Adj EPS $4.19-$4.34 vs $3.96 Est; Sees Sales $1.390B-$1.440B vs $1.347B Est
Dolby Laboratories (NYSE:DLB) is looking for FY2026 Adj EPS of $4.19-$4.34 vs $3.96 analyst estimate. sees sales of $1.390 billion-$1.440 billion vs $1.347 billion analyst estimate.